Out-patient management of febrile neutropenia

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 169-171

  Talcott, James A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Fever; Neutropenia; Out patient care; Risk assessment

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT;

ARTICLE; COST; FEBRILE NEUTROPENIA; HOSPITAL CARE; HUMAN; INFECTION; MORTALITY; OUTPATIENT; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT;

AMBULATORY CARE; ANTIBIOTICS; CLINICAL TRIALS; FEVER; HUMAN; NEUTROPENIA; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033775846     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00235-1     Document Type: Article

References (10)

1. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia
2. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia
3. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
4. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation
5. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule
6. Ambulatory treatment of febrile episodes in neutropenic patients (abstr)
7. Out-patient treatment of febrile episodes in low-risk neutropenic patients with cancer
8. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule
9. Feasibility of out-patient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial
10. Is it time to redefine the management of febrile neutropenia in cancer patients? [editorial; comment]